{"entity":{"id":"belarus-paediatric-oncology-centre","kind":"institution","name":"Belarusian Research Center for Pediatric Oncology, Hematology and Immunology","aka":["Republican Scientific Practical Centre for Paediatric Oncology, Haematology and Immunology","РНПЦ детской онкологии, гематологии и иммунологии"],"tldr":"Belarus's republican centre for children with cancer and blood disorders, in Minsk. It hosts the national resource centre for children's palliative care, and its genetic biotechnology laboratory took part in the trial of a CAR T-cell product made in Belarus.","summary":"The European Observatory's 2013 review names the Republican Scientific Practical Centre for Paediatric Oncology, Haematology and Immunology as home to the Republican Resource Centre for the Palliative Care of Children. The phase 1 trial of the CD19 CAR T-cell product BY19, published in 2025, lists the centre's Laboratory of Genetic Biotechnologies, Minsk (postal code 223053), among its authors; the trial was run at two Belarusian centres and treated 23 children and adults with relapsed or refractory B-cell cancers, 17 of them with B-cell acute lymphoblastic leukaemia. The coordinates are an approximate Minsk point, not the building.","asOf":"2026-11-11","links":[{"label":"European Observatory: Belarus health system review 2013, section 5.10 (palliative care)","url":"https://eurohealthobservatory.who.int/publications/i/belarus-health-system-review-2013"},{"label":"Katsin et al., CD19 CAR T cell therapy BY19 in Belarus: phase 1 trial (Mol Ther Oncol 2025)","url":"https://doi.org/10.1016/j.omton.2025.201081"}],"tags":[],"related":[],"cancers":["childhood-cancers","all-leukemia"],"sections":[],"technologies":["car-t"],"targets":[],"drugs":[],"companies":[],"institutions":["belarus-ministry-of-health","alexandrov-national-cancer-centre-belarus"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":["paper-katsin-by19-cd19-car-t-belarus-mol-ther-oncol-2025"],"journals":[],"dependsOn":[],"notes":[],"city":"Minsk","country":"BY","lat":53.95,"lng":27.62,"institutionType":"cancer-center","programs":["Treatment of childhood cancers and blood disorders","Republican Resource Centre for the Palliative Care of Children","Participation in the BY19 CD19 CAR T-cell trial"]},"route":"/institutions/belarus-paediatric-oncology-centre/","neighbours":{"cancer":[{"id":"all-leukemia","kind":"cancer","name":"Acute lymphoblastic leukaemia","route":"/cancers/all-leukemia/"},{"id":"childhood-cancers","kind":"cancer","name":"Childhood cancers (all types)","route":"/cancers/childhood-cancers/"}],"technology":[{"id":"car-t","kind":"technology","name":"CAR-T cell therapy","route":"/technologies/car-t/"}],"institution":[{"id":"belarus-ministry-of-health","kind":"institution","name":"Ministry of Health of the Republic of Belarus","route":"/institutions/belarus-ministry-of-health/"},{"id":"alexandrov-national-cancer-centre-belarus","kind":"institution","name":"N.N. Alexandrov National Cancer Centre of Belarus","route":"/institutions/alexandrov-national-cancer-centre-belarus/"}],"paper":[{"id":"paper-katsin-by19-cd19-car-t-belarus-mol-ther-oncol-2025","kind":"paper","name":"BY19: a CD19 CAR T-cell therapy made in Belarus, phase 1 trial","route":"/key-papers/paper-katsin-by19-cd19-car-t-belarus-mol-ther-oncol-2025/"}]}}